Moxifloxacin, Bromfenac, Prednisolone Acetate is a prescription medicine. The sections below reproduce one FDA label for it, named under "Label". Products in other forms, strengths or from other makers have their own labels, which can differ.
- Type
- Prescription only (Rx)
- Brand names
- Strenza Plus
- Taken
- Ophthalmic
- Label
- Brisk Pharmaceuticals, revised February 12, 2025 · full label on DailyMed
- Generic
- No · details
Is there a generic Moxifloxacin, Bromfenac, Prednisolone Acetate?
No. The FDA has not approved a generic version yet.
Source: Drugs@FDA (via openFDA), checked October 29, 2026. Marketing status is what companies report to the FDA; whether a pharmacy stocks a product, and what your insurance covers, can differ.
Dosage:
we do not reproduce dosing instructions. The right dose depends on the person and the condition and is set by the prescriber or pharmacist. Dosage section of the full label.
Moxifloxacin, bromfenac, prednisolone acetate in the news
We have not covered this medicine yet. Latest news
Recalls
No recalls matched to this medicine in FDA enforcement reports from the last 3 years (or older ones still open). Search all recalls
Get alerts for Moxifloxacin, Bromfenac, Prednisolone Acetate
We will email you if the FDA reports a recall, if its shortage status changes, or when we publish news about it — at most one email a day. No account needed.
Source: FDA structured product labeling, retrieved through openFDA. Label text is shown as published by the FDA, without editing; long sections are shortened, marked […]. openFDA data are not validated for clinical use — always check the current label and ask a doctor or pharmacist about your own treatment. Set ID 2df9064c-0527-4c21-e063-6294a90a56d8.